Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074850

« Back to Dashboard

NDA 074850 describes LEVOBUNOLOL HYDROCHLORIDE, which is a drug marketed by Alcon Labs Inc, Apotex Inc, Bausch And Lomb, and Sandoz Inc, and is included in six NDAs. It is available from one supplier. Additional details are available on the LEVOBUNOLOL HYDROCHLORIDE profile page.

The generic ingredient in LEVOBUNOLOL HYDROCHLORIDE is levobunolol hydrochloride. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.

Summary for 074850

Tradename:	LEVOBUNOLOL HYDROCHLORIDE
Applicant:	Sandoz Inc
Ingredient:	levobunolol hydrochloride
Patents:	0
Therapeutic Class:	Ophthalmic Agents

Medical Subject Heading (MeSH) Categories for 074850

Adrenergic beta-Antagonists
Sympatholytics

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	0.5%
Approval Date:	Oct 28, 1996	TE:	AT	RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson

Moodys

Covington

Colorcon

Boehringer Ingelheim

Queensland Health

US Department of Justice

Argus Health

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.